Sentence examples for language trials from inspiring English sources

Non-English language trials were translated and included whenever possible.

The prespecified search strategy excluded unpublished data and non-English language trials.

However, reanalysis of published meta-analysis including both English and non-English language trials found no consistent change in the summary estimates of meta-analyses when excluding non-English language trials.

It is also possible that some trials, such as potentially some non-English language trials, were not included.

The two non English language trials identified in the literature search were professionally translated to allow full inclusion and to prevent the introduction of language bias [ 45, 46].

In complementary medicine several meta-analyses resulted in significantly smaller summary result estimates when excluding non-English language trials [ 2- 4].

Even though CRA still works in the case of applying EFR normalization, its performance is not so good as in the case of without EFR normalization both in English trials and in multi-language trials.

For our system, best LDA dimension is 210 (in the case that dimension of total factor matrix is 400), standardization before LDA compensation (EFR norm four iterations) enhances the performance and gives a baseline of 2.35 % for EER and 0.0233 for DCF in the English trials (det7), 5.40 % for EER and 0.0525 for DCF in the multi-language trials (det6, all trials).

After applying CRA, as we reduce the number of components, EER and DCF decrease slightly, the best performance is obtained when the threshold R is 900, which gives a minimum EER of 2.15 and minimum DCF of 0.0207 in the English trials and a minimum EER of 5.10 and minimum DCF of 0.0503 in the multi-language trials.

For the comparison of German and English-language trials, a significant trend towards publication of statistically significant results in English-language journals was identified [ 1].

Using MEDLINE and EMBASE, we identified English-language trials published from 1990 to 2008 that included PEG and/or NaP, and aggregated them by treatment arm into: 4 liter (L) PEG; 2 L PEG; split-dose PEG; two 45 ml doses of NaP +/- adjunctive medication; and NaP tablets.